Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Brilaroxazine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 117,418Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Reviva Secures EU Patent for Brilaroxazine in Pulmonary Fibrosis
    Reviva Secures EU Patent for Brilaroxazine in Pulmonary Fibrosis

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184521/0/en/Reviva-Announces-Grant-of-European-Patent-Covering-Use-of-Brilaroxazine-for-the-Treatment-of-Pulmonary-Fibrosis.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Reviva Presents Brilaroxazine Ph 3 Schizophrenia Data at CNS 2025
    Reviva Presents Brilaroxazine Ph 3 Schizophrenia Data at CNS 2025

    28 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/28/3175313/0/en/Reviva-to-Present-Negative-Symptom-Data-for-Brilaroxazine-in-Schizophrenia-from-the-Phase-3-RECOVER-Double-Blind-and-Open-Label-Extension-Trials-at-the-CNS-Summit-2025.html

    GLOBENEWSWIRE
    28 Oct 2025
    Share Share
    Reviva Shows Full Ph3 RECOVER Data For Brilaroxazine In Schiz
    Reviva Shows Full Ph3 RECOVER Data For Brilaroxazine In Schiz

    02 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/02/3091710/0/en/Reviva-Announces-Positive-Full-Dataset-for-1-Year-Phase-3-RECOVER-Open-Label-Extension-Study-Evaluating-Brilaroxazine-in-Schizophrenia.html

    GLOBENEWSWIRE
    02 Jun 2025
    Share Share
    Reviva to Present Poster on RECOVER Trial at 2025 ASCP Meeting
    Reviva to Present Poster on RECOVER Trial at 2025 ASCP Meeting

    24 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/24/3067346/0/en/Reviva-to-Present-Late-Breaking-Poster-on-the-RECOVER-Long-term-Open-Label-Extension-Trial-for-Brilaroxazine-in-Schizophrenia-at-the-2025-ASCP-Annual-Meeting.html

    GLOBENEWSWIRE
    24 Apr 2025
    Share Share
    Reviva to Present Brilaroxazine Data at 2025 SIRS Congress
    Reviva to Present Brilaroxazine Data at 2025 SIRS Congress

    30 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/30/3051893/0/en/Reviva-to-Present-Brilaroxazine-Topline-Data-for-Long-Term-OLE-Portion-of-RECOVER-Study-in-Schizophrenia-at-2025-SIRS-Congress.html

    GLOBENEWSWIRE
    30 Mar 2025
    Share Share
    Reviva to Present Brilaroxazine Speech Data at CNS Summit 2024
    Reviva to Present Brilaroxazine Speech Data at CNS Summit 2024

    06 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/06/2975650/0/en/Reviva-to-Present-Positive-Speech-Latency-Data-for-Brilaroxazine-in-Schizophrenia-From-the-Phase-3-RECOVER-Trial-at-the-CNS-Summit-2024.html

    GLOBENEWSWIRE
    06 Nov 2024
    Share Share